Чубірко Ксенія І
ДВНЗ "УЖГОРОДСЬКИЙ НАЦІОНАЛЬНИЙ УНІВЕРСИТЕТ", ФАКУЛЬТЕТ ПІСЛЯДИПЛОМНОЇ ОСВІТИ ТА ДОУНІВЕРСИТЕТСЬКОЇ ПІДГОТОВКИ, КАФЕДРА ТЕРАПІЇ ТА СІМЕЙНОЇ МЕДИЦИНИ, УЖГОРОД, УКРАЇНА.
Wiad Lek. 2017;70(2):208-212.
The data of epidemiological researches confirm the tendency in increasing of non alcoholic fatty liver disease (NAFLD) in patients with insulin resistance which occurs because of obesity, diabetes type 2 and metabolic syndrome.
Optimization of diagnostic and treatment efficacy in patients with non alcoholic steatosis and steatohepatitis on the background of obesity.
General clinical examination of patients, laboratory and instrumental methods ( fatty liver index, non invasive assessment of liver, morphology, electrocardiography, treadmillergometry, ultrasound examination of abdominal organs, liver elastography,CT,MRI, methods of statistical analysis.
NAFLD was diagnosed in 98.4% of patients with diabetes type 2, from which steatosis was found in 54.84% and steatohepatitis in 45.16%. In individuals with prediabetes NAFLD was in 70.5%, of which 85.45% with steatosis and 14.55% steatohepatitis (p<0.05). The clinical picture of patients with NAFLD prevailed such symptoms and complaints: flatulence in 43.59% of patients, weakness and pain in the right upper quadrant in 29.9% of patients. Fewer patients complained on discomfort in abdomen 28.21%, constipation 21.37% and feeling of bitterness in the mouth 21.37%.
Clinical features of NAFLD are polysymptomatic. There are prevalence of dyspeptic syndromes (bloating met in 43.59% of patients, pain in right upper quadrant and discomfort in abdomen -29.91%, constipation- 28.21%, bitterness in mouth-21.37%. Determination of fatty liver index is very informative method of screening patients with hepatisteatosis.
流行病学研究数据证实,因肥胖、2型糖尿病和代谢综合征导致胰岛素抵抗的患者中,非酒精性脂肪性肝病(NAFLD)呈增加趋势。
优化肥胖背景下非酒精性脂肪变性和脂肪性肝炎患者的诊断和治疗效果。
对患者进行一般临床检查、实验室及仪器检查方法(脂肪肝指数、肝脏无创评估、形态学、心电图、运动平板试验、腹部脏器超声检查、肝脏弹性成像、CT、MRI、统计分析方法)。
98.4%的2型糖尿病患者被诊断为NAFLD,其中54.84%为脂肪变性,45.16%为脂肪性肝炎。糖尿病前期个体中NAFLD患病率为70.5%,其中85.45%为脂肪变性,14.55%为脂肪性肝炎(p<0.05)。NAFLD患者的临床表现以如下症状和主诉为主:43.59%的患者有肠胃胀气症状,29.9%的患者有右上腹无力和疼痛症状。较少患者主诉腹部不适(28.21%)、便秘(21.37%)和口苦(21.37%)。
NAFLD的临床特征具有多症状性。消化不良综合征较为普遍(43.59%的患者有肠胃胀气症状,右上腹疼痛和腹部不适占29.91%,便秘占28.21%,口苦占21.37%)。测定脂肪肝指数是筛查肝脂肪变性患者的非常有效的方法。